Successful delivery of DNA (a CpG motif-deleted plasmid expressing the human CFTR cDNA) using liposomes to the lungs of CF patients has been accomplished [9], and this is the largest CF gene therapy study using liposomes for CF treatment [9]. This evidence concerns the gene CFTR and cystic fibrosis.